Jacobs Levy Equity Management Inc. Lowers Stock Position in Integral Ad Science Holding Corp. (NASDAQ:IAS)

Jacobs Levy Equity Management Inc. decreased its holdings in shares of Integral Ad Science Holding Corp. (NASDAQ:IAS - Free Report) by 15.1% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 1,421,237 shares of the company's stock after selling 252,981 shares during the period. Jacobs Levy Equity Management Inc. owned approximately 0.87% of Integral Ad Science worth $14,838,000 as of its most recent SEC filing.

Other institutional investors have also recently bought and sold shares of the company. Alyeska Investment Group L.P. bought a new stake in shares of Integral Ad Science in the 4th quarter worth $41,543,000. Dimensional Fund Advisors LP grew its stake in shares of Integral Ad Science by 18.1% in the 4th quarter. Dimensional Fund Advisors LP now owns 3,789,996 shares of the company's stock worth $39,567,000 after acquiring an additional 580,323 shares in the last quarter. Clearline Capital LP bought a new stake in shares of Integral Ad Science in the 4th quarter worth $3,949,000. Ararat Capital Management LP grew its stake in shares of Integral Ad Science by 13.4% in the 4th quarter. Ararat Capital Management LP now owns 2,281,912 shares of the company's stock worth $23,823,000 after acquiring an additional 269,346 shares in the last quarter. Finally, JPMorgan Chase & Co. grew its stake in shares of Integral Ad Science by 47.6% in the 3rd quarter. JPMorgan Chase & Co. now owns 717,528 shares of the company's stock worth $7,756,000 after acquiring an additional 231,271 shares in the last quarter. Institutional investors and hedge funds own 95.78% of the company's stock.

Integral Ad Science Stock Performance

NASDAQ:IAS traded up $0.05 on Friday, reaching $8.09. 1,990,029 shares of the company's stock were exchanged, compared to its average volume of 1,032,019. The company has a debt-to-equity ratio of 0.07, a current ratio of 3.71 and a quick ratio of 3.71. The firm has a market cap of $1.33 billion, a price-to-earnings ratio of 40.45, a P/E/G ratio of 1.06 and a beta of 1.55. Integral Ad Science Holding Corp. has a 52 week low of $6.26 and a 52 week high of $13.62. The stock has a fifty day simple moving average of $7.67 and a 200-day simple moving average of $9.60.

Integral Ad Science (NASDAQ:IAS - Get Free Report) last issued its earnings results on Monday, May 12th. The company reported $0.05 earnings per share for the quarter, topping analysts' consensus estimates of $0.03 by $0.02. The firm had revenue of $134.07 million during the quarter, compared to analyst estimates of $129.20 million. Integral Ad Science had a net margin of 6.39% and a return on equity of 3.47%. As a group, sell-side analysts predict that Integral Ad Science Holding Corp. will post 0.26 earnings per share for the current year.

Insiders Place Their Bets

In other news, CEO Lisa Utzschneider sold 8,547 shares of the firm's stock in a transaction that occurred on Monday, April 7th. The shares were sold at an average price of $6.85, for a total value of $58,546.95. Following the completion of the transaction, the chief executive officer now directly owns 341,271 shares in the company, valued at approximately $2,337,706.35. This trade represents a 2.44% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders sold 86,222 shares of company stock worth $636,252 over the last quarter. 2.00% of the stock is currently owned by company insiders.

Analyst Ratings Changes

Several analysts have recently issued reports on the stock. Morgan Stanley reduced their target price on shares of Integral Ad Science from $13.50 to $12.50 and set an "equal weight" rating for the company in a research note on Thursday, April 17th. Scotiabank assumed coverage on shares of Integral Ad Science in a report on Friday, February 28th. They set a "sector perform" rating and a $12.00 price objective for the company. Benchmark restated a "hold" rating on shares of Integral Ad Science in a report on Friday, February 28th. Truist Financial raised their price objective on shares of Integral Ad Science from $16.00 to $17.00 and gave the stock a "buy" rating in a report on Monday, March 3rd. Finally, Barclays raised their price objective on shares of Integral Ad Science from $7.00 to $9.00 and gave the stock an "equal weight" rating in a report on Tuesday, May 13th. Six equities research analysts have rated the stock with a hold rating and six have issued a buy rating to the company. Based on data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and an average target price of $13.55.

Integral Ad Science Company Profile

Integral Ad Science Holding Corp. operates as a digital advertising verification company in the United States, the United Kingdom, France, Ireland, Germany, Italy, Singapore, Australia, Japan, India, and the Nordics. The company provides IAS Signal, a cloud-based technology platform that offers return on ad spend needs; and deliver independent measurement and verification of digital advertising across devices, channels, and formats, including desktop, mobile, connected TV, social, display, and video.